Colchicine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
An anti-inflammatory alkaloid derived from the autumn crocus plant, used for the treatment and prevention of gout flares and for familial Mediterranean fever. Colchicine has also shown cardiovascular benefit in reducing recurrent cardiovascular events (COLCOT trial) and pericarditis. It has a narrow therapeutic index requiring careful dosing.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
An anti-inflammatory alkaloid derived from the autumn crocus plant, used for the treatment and prevention of gout flares and for familial Mediterranean fever. NutriStack rates the supporting evidence as strong. Common adult dosing is Acute gout flare: 1.2 mg at first sign, then 0.6 mg one hour later (max 1.8 mg per flare); Prophylaxis: 0.6 mg once or twice daily (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 11 sources.
- Diarrhea (most common, dose-limiting)
- Nausea and vomiting
- Abdominal cramping
- Concurrent use of strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) in patients with renal or hepatic impairment
- Severe renal impairment requiring dialysis
The bottom line
Evidence rating strong. Most-documented uses: treatment of acute gout flares, prophylaxis against gout flares during urate-lowering therapy initiation, treatment of familial mediterranean fever. 11 sources indexed (2020–2026), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds to tubulin and inhibits its polymerization into microtubules, disrupting multiple inflammatory processes. This inhibits neutrophil migration to sites of urate crystal deposition, impairs neutrophil phagocytosis and degranulation, reduces inflammasome (NLRP3) activation and IL-1 beta release, and decreases leukotriene B4 and prostaglandin production. The overall effect is a potent reduction in the inflammatory response to monosodium urate crystals.
Dosing & protocol.
Can be taken with or without food; reduce dose or avoid with strong CYP3A4 or P-glycoprotein inhibitors1,6
Full safety detail.
Side effects
- Diarrhea (most common, dose-limiting)
- Nausea and vomiting
- Abdominal cramping
- Myopathy and rhabdomyolysis (especially with statins or renal impairment)
- Bone marrow suppression (with chronic high-dose use)
- Peripheral neuropathy (rare, with chronic use)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
6- 1Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects WorldwidePMIDLi HY, Cheriyan J, Chan TK et al. · American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
Li HY, Cheriyan J, Chan TK et al.. Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2026
- 2The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trialsPMIDYounas A, Awan Z, Khan T et al. · Current problems in cardiology · 2025
Younas A, Awan Z, Khan T et al.. The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trials. Current problems in cardiology. 2025
- 3Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trialsPMIDXie S, Galimberti F, Olmastroni E et al. · Journal of internal medicine · 2025
Xie S, Galimberti F, Olmastroni E et al.. Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trials. Journal of internal medicine. 2025
- 4Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular DiseasePMIDAkl E, Sahami N, Labos C et al. · Journal of interventional cardiology · 2024
Akl E, Sahami N, Labos C et al.. Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease. Journal of interventional cardiology. 2024
- 5A systematic review of the drug-drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategiesPMIDSchwier NC, Cornelio CK, Boylan PM · Pharmacotherapy · 2022
Schwier NC, Cornelio CK, Boylan PM. A systematic review of the drug-drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies. Pharmacotherapy. 2022
- 6Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trialsPMIDFiolet ATL, Opstal TSJ, Mosterd A et al. · European heart journal · 2021
Fiolet ATL, Opstal TSJ, Mosterd A et al.. Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials. European heart journal. 2021
Randomized controlled trials
1- 7Low-dose colchicine for secondary prevention of cardiovascular disease (LoDoCo2)Source linkedPMIDNidorf SM, Fiolet ATL, Mosterd A et al. · N Engl J Med · 2020
Reference material
4- 8Tardif JC et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction (COLCOT trial). N Engl J Med. 2019.Source linkedPMID
- 9FitzGerald JD et al. 2020 American College of Rheumatology Guideline for Management of Gout. Arthritis Care Res. 2020.Source linkedPMID
- 10Terkeltaub RA et al. High versus low dosing of oral colchicine for early acute gout flare. Arthritis Rheum. 2010.Source linkedPMID
- 11Deftereos SG, Beerkens FJ, Shah B et al.. Colchicine in Cardiovascular Disease: In-Depth Review. Circulation. 2022Source linkedPMID
Common questions.
Quick answers about Colchicine, drawn from the data on this page.
What is Colchicine?
An anti-inflammatory alkaloid derived from the autumn crocus plant, used for the treatment and prevention of gout flares and for familial Mediterranean fever. Colchicine has also shown cardiovascular benefit in reducing recurrent cardiovascular events (COLCOT trial) and pericarditis. It has a narrow therapeutic index requiring careful dosing.
What is Colchicine used for?
Commonly cited benefits of Colchicine include: Treatment of acute gout flares; Prophylaxis against gout flares during urate-lowering therapy initiation; Treatment of familial Mediterranean fever; Cardiovascular event reduction (post-MI, per COLCOT trial); Treatment and prevention of recurrent pericarditis. NutriStack rates the overall evidence as strong.
What is a typical dose of Colchicine?
A typical adult dose of Colchicine is Acute gout flare: 1.2 mg at first sign, then 0.6 mg one hour later (max 1.8 mg per flare); Prophylaxis: 0.6 mg once or twice daily (as prescribed by your physician). The commonly recommended form is Tablet or capsule. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Colchicine?
Reported side effects include diarrhea (most common, dose-limiting), nausea and vomiting, abdominal cramping, myopathy and rhabdomyolysis (especially with statins or renal impairment), bone marrow suppression (with chronic high-dose use), peripheral neuropathy (rare, with chronic use). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Colchicine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Colchicine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.